Further, GSEA enrichment analysis revealed RelA-WT cells were enriched in MES signature whereas RelA-MUT cells were enriched in a PN signature (Figure 2I), suggesting that the inhibition of RelA K310 acetylation in the context of PTEN loss could potentially reverse PN to MES transition in GBM. Here, PTEN is linked to glioblastoma.